Exosome Technology Market

Exosome Technology Market

  • HC-2900
  • 4.8 Rating
  • 182 Pages
  • Upcoming
  • 60 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

The Global Exosome Technology Market size was valued at USD 47.3 Million in 2022 and is expected to surpass USD 347.37 Million by 2031, expanding at a CAGR of 24.8% during the forecast period, 2023 – 2031. Exosomes are nanometer-sized extracellular vesicles that produce almost all human body cells in order to carry out the crucial role of intercellular transportation of proteins and RNA. Exosomes are also defined as key mediators of cell to cell communications as they deliver lipids, nucleic acids, and proteins that reflect their cell of origin.

These technologies have a large number of therapeutic applications such as drug delivery systems and biomarkers. As a result, they are largely used to perform therapies for treating diseases such as cancer, cardiovascular diseases, neurodegenerative diseases, and infectious diseases. These extracellular vesicles are claimed by researchers to be a possible solution for improving lung immunity and thus significantly reduce lung diseases.

Exosome Technology Market Outlook

Different cells perform different functions and an exosome released by a regenerative cell is a potent driver of repair and healing. The advancement in technology as well as improved observation and research of these exosome vesicles is proving great insight for diagnostic of several serious diseases in their early stages. Exosome technology is a relatively new technology and has a huge potential of development and discovery.

Market Trends, Drivers, Restraints, and Opportunities:

  • The COVID-19 pandemic outbreak has led to many pharmaceutical and biotech companies to invest heavily in these diagnostics technology. This is a key factor driving the market growth.

  • Rise in prevalence of chronic diseases and presence of a large number of people suffering from such illness are major drivers of the market.

  • Heavy investment in exosome technology by the cosmetics industry as it has a large potential in skin healing and repairing present a key factor boosting the market.

  • Increase in awareness about the technology and favorable government initiatives encouraging the development of advanced techniques for several healthcare devices are the key factors anticipated to propel the market during the forecast period.

  • Low purity, storage stability, and weak targeting of exosomes are some of the major restraints responsible for hindering market growth.

  • Massive investment in this technology and growing R&D programs for the development of innovative technology are creating immense opportunities for growth of the market.

Scope of the Exosome Technology Market Report:

The report on the global exosome technology market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Exosome Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Loaded Cargo [Peptide, siRNA, mRNA, Protein, and Chemical] and Non-cargo), Cell Sources (HEK293, MSCs, Platelets, Erythrocytes, and Natural Killer Cells), Applications (Therapeutic [Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, and Cosmetics] and Diagnostic)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Aegle Therapeutics; Anjarium Biosciences AG; and Carmine Therapeutics, Inc.

 

Exsome Technology Market Segment Insights

Loaded cargo segment to constitute large market share

In terms of types, the exosome technology market is bifurcated into loaded cargo and non-cargo segments. The loaded cargo segment is further segmented into peptide, siRNA, mRNA, protein, and chemical. The loaded cargo segment is expected to constitute large market share during the forecast period as it enables therapeutic to naturally cross the blood-brain barriers.

Loaded cargo exosome contains various types of natural components including proteins, nucleic acids, and lipids, which can help achieve better therapeutic efficiency in treating and diagnosing chronic brain diseases. These features of the loaded cargo segment are responsible for market growth.

MSCs segment to hold significant share in the market

Based on cell sources, the market is divided into HEK293, MSCs, platelets, erythrocytes, and natural killer cells. The MSCs segment is projected to hold significant share in the market in the coming years as it regulates several cells involved in immune responses due to its immunomodulatory properties. It is claimed to exhibit potent cell therapeutics for various chronic diseases in recent years. All these factors are key factors contributing to the significant market growth of this segment.

Exosome Technology Market Cell Sources

Favorable reimbursement policy drives the diagnostic segment

On the basis of applications, the exosome technology market is bifurcated into diagnostics and therapeutics. The therapeutics segment is further divided into oncology, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and cosmetics.

The diagnostic segment is anticipated to hold a major share in the market during the forecast period. The segment growth is attributed to favorable reimbursement policies along with the availability and approval of several new diagnostics methods as well as the large-scale advancement in technology.

Exosome Technology Market Applications

North America to account for a key market share

In terms of regions, the market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North American is anticipated to account for a key market share during the forecast period owing to the early adoption of well-developed infrastructure as well as the presence of several big players in this region.

Exosome Technology Market Regions

Segments

By Types

  • Loaded Cargo
    • Peptide
    • siRNA
    • mRNA
    • Protein
    • chemical
  • Non-cargo

By Cell Sources

  • HEK293
  • MSCS
  • Platelets
  • Erythrocytes
  • Natural Killer Cells

By Applications

  • Diagnostic
  • Therapeutic
    • Oncology
    • Neurodegenerative Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Cosmetics

By regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

By Key Players

Competitive Landscape

Key players in the global exosome technology market are Aegle Therapeutics; Anjarium Biosciences AG; and Carmine Therapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Exosome Technology Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Exosome Technology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Exosome Technology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Exosome Technology Market - Supply Chain
  4.5. Global Exosome Technology Market Forecast
     4.5.1. Exosome Technology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Exosome Technology Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Exosome Technology Market Absolute $ Opportunity
5. Global Exosome Technology Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Exosome Technology Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Exosome Technology Demand Share Forecast, 2019-2026
6. North America Exosome Technology Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Exosome Technology Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Exosome Technology Demand Share Forecast, 2019-2026
7. Latin America Exosome Technology Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Exosome Technology Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Exosome Technology Demand Share Forecast, 2019-2026
8. Europe Exosome Technology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Exosome Technology Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Exosome Technology Demand Share Forecast, 2019-2026
9. Asia Pacific Exosome Technology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Exosome Technology Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Exosome Technology Demand Share Forecast, 2019-2026
10. Middle East & Africa Exosome Technology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Exosome Technology Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Exosome Technology Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Exosome Technology Market: Market Share Analysis
  11.2. Exosome Technology Distributors and Customers
  11.3. Exosome Technology Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Aegle Therapeutics
     11.4.2. Anjarium Biosciences AG
     11.4.3. Carmine Therapeutics, Inc.

Purchase Premium Report